Your browser doesn't support javascript.
loading
COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models.
Kim, Hyeong Seok; Sharma, Amit; Ren, Wen Xiu; Han, Jiyou; Kim, Jong Seung.
Afiliação
  • Kim HS; Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea.
  • Sharma A; Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea.
  • Ren WX; Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, PR China; Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea. Electronic address: xrenwenxiux@hotmail.com.
  • Han J; Department of Biological Sciences, Laboratory of Stem Cell Research and Biotechnology, Hyupsung University, Hwasung-si, 18330, Republic of Korea. Electronic address: hanjiyou12@hanmail.net.
  • Kim JS; Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea. Electronic address: jongskim@korea.ac.kr.
Biomaterials ; 185: 63-72, 2018 12.
Article em En | MEDLINE | ID: mdl-30223141
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Indometacina / Inibidores da Angiogênese / Inibidores de Ciclo-Oxigenase 2 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Indometacina / Inibidores da Angiogênese / Inibidores de Ciclo-Oxigenase 2 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article